47. Buerger disease Clinical trials / Disease details
Clinical trials : 9 / Drugs : 13 - (DrugBank : 7) / Drug target genes : 6 - Drug target pathways : 15
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01447550 (ClinicalTrials.gov) | January 2009 | 5/10/2011 | Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan | Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan | Thromboangiitis Obliterans | Drug: Bosentan | Hospital Universitario Getafe | NULL | Completed | 18 Years | 65 Years | Both | 12 | N/A | Spain |